Imrab Rabies Vaccine

Verify with FDA CVM →

13 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
13
Total Reports
4
Deaths Reported
3080.0%
Death Rate

Active Ingredients

Imrab Rabies Vaccine

Administration Routes

UnknownSubcutaneousOtherIntramuscular

Species Affected

Dog 8
Horse 3
Cat 2

Most Affected Breeds

Retriever - Labrador 2
Domestic Shorthair 2
Mustang 2
Pug 1
Boxer (German Boxer) 1
Collie - Border 1
Crossbred Canine/dog 1
Poodle - Toy 1
Papillon - Spaniel - Continental Toy (with erect ears or with dropped ears (Phaléne)) 1
Quarter Horse 1

Most Reported Reactions

Vomiting 4
Diarrhoea 4
Unresponsive to stimuli 2
Death 2
Muscle tremor 2
Emesis (multiple) 2
Not eating 2
Not drinking 2
Hyperaemic mucous membrane 2
Impaired gastric function 2
Elevated lactate 2
Death by euthanasia 2

Outcome Breakdown

Ongoing
6 (46.2%)
Recovered/Normal
3 (23.1%)
Died
2 (15.4%)
Euthanized
2 (15.4%)

Data Summary

Metric Value
Total adverse event reports 13
Reports involving death 4
Case-fatality rate (reported events) 3080.0%
Distinct species in reports 3
Distinct breeds in reports 10
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Imrab Rabies Vaccine Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 13 adverse event reports referencing Imrab Rabies Vaccine, including 4 reports in which the animal died — a 3080.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Imrab Rabies Vaccine. Reported administration routes include Unknown, Subcutaneous, Other, Intramuscular. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Imrab Rabies Vaccine reports are Dog (8 reports), Horse (3 reports), Cat (2 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (2), Domestic Shorthair (2), Mustang (2) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Imrab Rabies Vaccine are Vomiting (4), Diarrhoea (4), Unresponsive to stimuli (2), Death (2). Of the 13 reports with a coded outcome, Ongoing is the leading category at 46.2%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Imrab Rabies Vaccine.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial